Abstract:Background-Oxidative stress, an excessive production of reactive oxygen species (ROS) outstripping antioxidant defense mechanisms, occurs in cardiovascular pathologies, including hypertension. In the present study, we used biochemical, physiological, and pharmacological approaches to explore the role of derangements of catecholamines, ROS, and the endothelium-derived relaxing factor nitric oxide (NO center dot) in the development of a hyperadrenergic model of hereditary hypertension: targeted ablation (knockout [KO]) of chromogranin A (Chga) in the mouse.Methods and Results-Homozygous (-/-) Chga gene knockout (KO) mice were compared with wild-type (WT, +/+) control mice. In the KO mouse, elevations of systolic and diastolic blood pressure were accompanied by not only elevated catecholamine (norepinephrine and epinephrine) concentrations but also increased ROS (H2O2) and isoprostane (an index of lipid peroxidation), as well as depletion of NO center dot. Renal transcript analyses implicated changes in Nox1/2, Xo/Xdh, and Sod1,2 mRNAs in ROS elevation by the KO state. KO alterations in blood pressure, catecholamines, H2O2, isoprostane, and NO center dot could be abrogated or even normalized (rescued) by either sympathetic outflow inhibition (with clonidine) or NADPH oxidase inhibition (with apocynin). In cultured renal podocytes, H2O2 production was substantially augmented by epinephrine (probably through beta 2-adrenergic receptors) and modestly diminished by norepinephrine (probably through alpha(1)-adrenergic receptors).Conclusions-ROS appear to play a necessary role in the development of hyperadrenergic hypertension in this model, in a process mechanistically linking elevated blood pressure with catecholamine excess, renal transcriptional responses, ROS elevation, lipid peroxidation, and NO center dot depletion. Some of the changes appear to be dependent on transcription, whereas others are immediate. The cycle could be disrupted by inhibition of either sympathetic outflow or NADPH oxidase. Because common genetic variation at the human CHGA locus alters BP, the results have implications for antihypertensive treatment as well as prevention of target-organ consequences of the disease. The results document novel pathophysiological links between the adrenergic system and oxidative stress and suggest new strategies to probe the role and actions of ROS within this setting. (Circ Cardiovasc Genet. 2010;3:414-425.)

Catecholamine Storage Vesicles: Role of Core Protein Genetic Polymorphisms in Hypertension.

Naturally Occurring Genetic Variants in Human Chromogranin A (CHGA) Associated with Hypertension As Well As Hypertensive Renal Disease

Naturally Occurring Human Genetic Variation in the 3′-Untranslated Region of the Secretory Protein Chromogranin A is Associated with Autonomic Blood Pressure Regulation and Hypertension in a Sex-Dependent Fashion

Chromogranin A Polymorphisms Are Associated with Hypertensive Renal Disease.

Molecular Mechanism for Hypertensive Renal Disease

Disorders of Blood Pressure Regulation—Role of Catecholamine Biosynthesis, Release, and Metabolism

Role of Reactive Oxygen Species in Hyperadrenergic Hypertension Biochemical, Physiological, and Pharmacological Evidence from Targeted Ablation of the Chromogranin A (chga) Gene

Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.

Identification of Novel Loci Affecting Circulating Chromogranins and Related Peptides

A Common Genetic Variant in the 3 '-Utr of Vacuolar H+-Atpase Atp6v0a1 Creates A Micro-Rna Motif to Alter Chromogranin A Processing and Hypertension Risk

Effect of chromogranin A on central autonomic control of blood pressure

Heredity of Endothelin Secretion

Heredity Of Endothelin Secretion - Human Twin Studies Reveal The Influence Of Polymorphism At The Chromogranin A Locus, A Novel Determinant Of Endothelial Function

Genetic Variation at the Delta-Sarcoglycan (SGCD) Locus Elevates Heritable Sympathetic Nerve Activity in Human Twin Pairs.

Genetic Polymorphisms in the Renin–angiotensin System: Relevance for Susceptibility to Cardiovascular Disease

Abstract P152: Chromatin Accessibility Landscape of the Proximal Tubule and Thick Ascending Limb in Humans and Rats

Association Between Common Genetic Variants of Α2a-, Α2b-, and Α2c-Adrenergic Receptors and Orthostatic Hypotension.

A Variant in the Nicotinic Acetylcholine Receptor Alpha 3 Subunit Gene Is Associated With Hypertension Risks in Hypogonadic Patients

Relationship Between Genetic Variants of ACE 2 Gene and Circulating Levels of ACE 2 and Its Metabolites

Rare Variants in Genes Encoding Subunits of the Epithelial Na + Channel Are Associated with Blood Pressure and Kidney Function

Abstract 14011: Rare Variants in GUCY1A3 Gene Contribute to Hypertension Via NO/cGMP Pathway